Colorectal Cancer Screening Market Set for Rapid Growth and Trend by 2023 | Analysis by Alere, Clinical Genomics, Beckman Coulter, Abbott, Exact Sciences, Hemosure, Eiken Chemical, Quidel

Marketprognosis.com Publish a New Market Research Report On “Global Colorectal Cancer Screening Market 2019 - 2023” which contains global key player’s survey information and forecast to 2023.

Overview of the Global Colorectal Cancer Screening Market:

The report spread across 115 pages is an overview of the Global Colorectal Cancer Screening Market. These report study based on the Colorectal Cancer Screening Market. It is a complete overview of the market, covering various aspects prevailing market landscape. It accumulates comprehensive information and research methodologies.

The Global Colorectal Cancer Screening Market has been estimated at USD 727.08 Million for 2017. The Global Colorectal Cancer Screening Market is expected to register a CAGR of 4.38% during the forecast period, 2018 to 2023. Asia-Pacific is expected to have a substantial growth in the forecast period.

Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/16728 .

The Advent of Efficacious Genetic Tests; Genetic testing for colon cancer creates better opportunity for early diagnosis. It is highly recommended by the medical community. Screening for the mutations that cause colon cancer is only beginning to be done outside the research labs. If these medical screenings are implemented, then the number of colon cancer cases found in the early stages would increase. Also, a gene therapy to alter these mutations is likely to be developed. The increasing awareness about genetic screening methods and advantages in undergoing the testu2014not for early detection and treatment but also for removal of precancerous cells, which is much cheaper than the usual run of chemotherapyu2014is driving the market.

High Screening Tests Cost; Many high-income countries, including the United Kingdom and the United States, are facing the challenge of providing care to an ever-increasing population of patients with cancer, owing to expensive screening and treatment. Though the CRC screening tests have potential for early disease detection, they are seldom used. The high cost of these tests is hindering the market growth. The spending associated with a CRC diagnosis increases quickly, even if one has insurance. Although many private insurance plans cover the costs for colonoscopy as a screening test, patients still might be charged for some services, which is again a burden. Not all screening test costs are covered by insurance companies.

As per the regional analysis, North America is dominating the Colorectal Cancer Screening Tests Market due to high incidences of colorectal cancer and rise of the geriatric population in the North American region. Colon cancer is reported to be America’s second deadliest cancer with 50,000 deaths, annually, followed by lung cancer. Rising incidence of colorectal cancer is driving the market in the United States; approximately 1, 44,000 cases of colorectal cancer were found in 2015 in the country and 1, 60, 000 new cases for colorectal cancer are expected to occur by 2020. This increase in the disease occurrence will eventually increase the demand for colorectal cancer screening procedures.

Purchase this report online with 115 Pages, Top Key Players Analysis and List of Tables & Figure @ https://marketprognosis.com/buyReport/16728 .

Major Key Players:

1 Alere Inc

2 Clinical Genomics

3 Beckman Coulter

4 Abbott Laboratories

5 Exact Sciences Corp

6 Hemosure

7 Eiken Chemical

8 Quidel Corporation

9 Novigenix SA and More……………..

Any Query? Ask to our Expert @ https://marketprognosis.com/enquiry/16728 .

This study answers to the below key questions:

1 What will the market size be in 2023 and what will the growth rate be?

2 What are the key market trends?

3 What are the challenges to market growth?

4 Who are the key players in this market?

5 What are the market opportunities and threats faced by the key players?

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Colorectal Cancer Screening Market.

Table of Contents:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Key Inferences

5 Market Overview

6 Drivers, Restraints, Opportunities and Challenges Analysis (Droc)

7 Market Segmentation

8 Competitive Landscape

9 Key Players

10 Future Outlook of the Market

About us:

We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:

ProgMark Pvt. Ltd.

Thane – 421501

India.

sales@marketprognosis.com

+1 973 241 5193

https://www.marketprognosis.com

This release was published on openPR.